Novartis AG (NVS)
NEO
Closed
Aug 18, 2026
Day's Range
29.8352 wk Range
22.65Overview - NVS - Novartis AG
Key Statistics
Valuation
Enterprise Value
450.10B
P/E (Trailing)
‪18.80‬
PEG Ratio
‪-1.91‬
Price / Sales (TTM)
‪7.51‬
Price / Book
‪9.80‬
EV / EBITDA
‪19.46‬
Profitability
Gross Margin
‪74.42%‬
Profit Margin
‪75.82%‬
Operating Margin
‪30.87%‬
Return on Assets
‪12.60%‬
Return on Equity
‪30.04%‬
Ownership
Shares Outstanding
1.90B
Dividends
Frequency
Annual
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - NVS - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NEO.
- NVSNEONovartis AG437.73BMarket Cap+25.62%52-week change18.81P/E (Trailing)‪24.74%‬Profit Margin
- ABBVNEOAbbVie Inc. CDR644.36BMarket Cap+20.06%52-week change194.37P/E (Trailing)‪4.00%‬Profit Margin
- ROCHNEORoche Holding Ltd.472.53BMarket Cap+28.63%52-week change10.18P/E (Trailing)‪19.60%‬Profit Margin
- AMGNNEOAmgen Inc. Canadian Depositary Receipt275.72BMarket Cap+18.43%52-week change33.21P/E (Trailing)‪17.38%‬Profit Margin
- GILDNEOGilead Sciences Inc. CDR221.12BMarket Cap+11.69%52-week change20.59P/E (Trailing)‪27.88%‬Profit Margin
- ZLLYNEOEli Lilly and Company Canadian Depositary Receipt11.63BMarket Cap+13.72%52-week change0.33P/E (Trailing)‪34.98%‬Profit Margin
Profile Summary - NVS - Novartis AG
About
Novartis AG American Depositary Receipt is an ADR that enables U.S. investors to access shares of Novartis AG, a leading global healthcare company headquartered in Basel, Switzerland. This financial instrument represents ownership in the Swiss-based pharmaceutical giant, traded since May 11, 2000, on major U.S.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
